Skip to main content

Table 3 Performance of HPV16/18 genotyping, cytology, and S5 methylation for detecting (His)HSIL+

From: Evaluation of a methylation classifier for predicting pre-cancer lesion among women with abnormal results between HPV16/18 and cytology

 

Sensitivity % (95% CI)

Specificity % (95% CI)

PPV % (95% CI)

NPV % (95% CI)

HPV16/18+

64.4 (57.8–72.1)

44.9 (40.5–49.1)

74.6 (71.3–76.8)

33.3 (29.3–38.2)

Cytology ≥(TCT)HSIL+

48.9 (42.8–53.2)

54.4 (50.3–58.4)

73.1 (70.5–75.9)

29.7 (25.4–34.8)

S5 cutoff 2.85

89.1 (86.2–92.4)

76.6 (72.2–78.9)

90.6 (87.2–93.1)

73.5 (69.6–75.7)

S5 cutoff 0.8

98.3 (94.8–99.2)

20.9 (17.1–25.8)

75.8 (70.0–81.4)

85.7 (80.7–89.3)

S5 cutoff 3.7

77.9 (72.5–83.9)

80.2 (76.1–85.0)

90.8 (86.6–94.3)

59.0 (55.9–63.7)

  1. (His)HSIL+ histological high-grade squamous intraepithelial lesion or worse, PPV positive predictive value, NPV negative predictive value